Gene · 3623
Papers1,777
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,777
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Patterns of Multidrug Resistance and Treatment Outcomes Among Pulmonary Tuberculosis Patients in Bangladesh. | Pathogens | 2026 | 41754460 | PubTator, text mining | PubMed |
| Tuberculosis Diagnostic Methods: Clinical Applicability, Implementation Challenges, and Integrated Testing Strategies. | Pathogens | 2026 | 41754394 | PubTator, text mining | PubMed |
| Immunization Against a Conserved Short 13-Amino Acid Receptor-Binding Epitope of FSHβ Reduces Spermatogenesis and Sperm Motility in Male Mice. | Vaccines (Basel) | 2026 | 41746104 | PubTator, text mining | PubMed |
| Drug resistance mechanisms in Mycobacterium tuberculosis infection and challenges in vaccine development. | Front Pharmacol | 2026 | 41737548 | PubTator, text mining | PubMed |
| Targeted and whole-genome sequencing for drug resistance and genetic relatedness inference of rifampicin-resistant Mycobacterium tuberculosis: an in-depth comparison. | ERJ Open Res | 2026 | 41736736 | PubTator, text mining | PubMed |
| The complete genome sequencing data of Priestia aryabhattai SPCL1 isolated from a heavy metal leachate-contaminated soil in Queretaro, México. | Data Brief | 2026 | 41732370 | PubTator, text mining | PubMed |
| In Silico Approaches in Benzimidazole Derivatives Research: Recent Insights. | Zhongguo Ying Yong Sheng Li Xue Za Zhi | 2026 | 41688124 | PubTator, text mining | PubMed |
| FOXI3 establishes the ectodermal niche in pharyngeal arches for cranial neural crest cells and their lineages. | Bone Res | 2026 | 41639043 | PubTator, text mining | PubMed |
| Diagnostic performance of the FluoroType MTBDR assay for rifampicin and isoniazid resistance in routine laboratory setting. | Afr J Prim Health Care Fam Med | 2026 | 41630661 | PubTator, text mining | PubMed |
| Discovery of pyridomycin derivatives as InhA inhibitors from actinomycetes through molecular networking and an In-House tandem mass library. | Nat Prod Bioprospect | 2026 | 41622375 | PubTator, text mining | PubMed |
| Integrated approach to design 5-indolyl-pyrazoles as anti-TB agent. | Bioorg Med Chem Lett | 2026 | 41621722 | PubTator, text mining | PubMed |
| Ovarian Thecal Metaplasia of the Adrenal Gland: A Contemporary Case Series With Immunohistochemistry. | Int J Surg Pathol | 2026 | 41533747 | PubTator, text mining | PubMed |
| Plasticizer mixture exposure-induced preeclampsia pathogenesis: Integrated single-cell and bulk transcriptomics, network toxicology, and molecular docking insights. | Food Chem Toxicol | 2026 | 41443393 | PubTator, text mining | PubMed |
| Pharmacogenomics and mutation informatics: correlation of NAT2 mutations and isoniazid acetylation rate. | Drug Discov Today | 2026 | 41314532 | PubTator, text mining | PubMed |
| Key role for inhibins in effective T cell activation, migration and Th17 differentiation. | FEBS Open Bio | 2026 | 40883994 | PubTator, text mining | PubMed |
| Discovery of highly potent α-keto ester-based peptidomimetic inhibitors of the Hip1 protease for the treatment of Mycobacterium tuberculosis. | Eur J Med Chem Rep | 2025 | 41929655 | PubTator, text mining | PubMed |
| Artificial intelligence for screening drug resistance in tuberculosis. | Indian J Med Res | 2025 | 41648958 | PubTator, text mining | PubMed |
| An explainable artificial intelligence framework reveals mutations associated with drug resistance in Mycobacterium tuberculosis. | Biosaf Health | 2025 | 41541062 | PubTator, text mining | PubMed |
| Characterization of Drug Resistance Patterns, Mutation Profiles and Prevalence of Mycobacterium tuberculosis in Shaoxing. | Infect Drug Resist | 2025 | 41394331 | PubTator, text mining | PubMed |
| Design, synthesis, bioactivity evaluation, and molecular modeling of pyridin-2-yl-pyrimidine: Potential Antimicrobial and anti-tuberculosis agents. | Bioorg Chem | 2025 | 41187399 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3623/papers?page=2